Dendritic cells and cytokines in immune rejection of cancer
- PMID: 18054517
- DOI: 10.1016/j.cytogfr.2007.10.003
Dendritic cells and cytokines in immune rejection of cancer
Abstract
Dendritic cells (DCs) play a crucial role in linking innate and adaptive immunity and, thus, in the generation of a protective immune response against both infectious diseases and tumors. The ability of DCs to prime and expand an immune response is regulated by signals acting through soluble mediators, mainly cytokines and chemokines. Understanding how cytokines influence DC functions and orchestrate the interactions of DCs with other immune cells is strictly instrumental to the progress in cancer immunotherapy. Herein, we will illustrate how certain cytokines and immune stimulating molecules can induce and sustain the antitumor immune response by acting on DCs. We will also discuss these cytokine-DC interactions in the light of clinical results in cancer patients.
Similar articles
-
IFN-alpha in the generation of dendritic cells for cancer immunotherapy.Handb Exp Pharmacol. 2009;(188):295-317. doi: 10.1007/978-3-540-71029-5_14. Handb Exp Pharmacol. 2009. PMID: 19031032 Review.
-
Targeting dendritic cells with antigen-containing liposomes: antitumour immunity.Expert Opin Biol Ther. 2004 Nov;4(11):1735-47. doi: 10.1517/14712598.4.11.1735. Expert Opin Biol Ther. 2004. PMID: 15500402 Review.
-
Dendritic cell-based cancer immunotherapies.Arch Immunol Ther Exp (Warsz). 2009 May-Jun;57(3):189-98. doi: 10.1007/s00005-009-0025-x. Epub 2009 May 29. Arch Immunol Ther Exp (Warsz). 2009. PMID: 19479202 Review.
-
Dendritic cells and their role in cancer immunotherapy.Iran J Immunol. 2007 Sep;4(3):127-44. Iran J Immunol. 2007. PMID: 17767012 Review.
-
Dendritic cells from bench to bedside and back.Immunol Lett. 2009 Feb 21;122(2):128-30. doi: 10.1016/j.imlet.2008.11.017. Epub 2008 Dec 31. Immunol Lett. 2009. PMID: 19121337 Review.
Cited by
-
Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape.J R Soc Interface. 2017 Jun;14(131):20170105. doi: 10.1098/rsif.2017.0105. J R Soc Interface. 2017. PMID: 28659412 Free PMC article.
-
Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience.J Biomed Biotechnol. 2010;2010:692097. doi: 10.1155/2010/692097. Epub 2010 Jun 2. J Biomed Biotechnol. 2010. PMID: 20625438 Free PMC article. Review.
-
Interferon-α-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12.PLoS One. 2011 Feb 28;6(2):e17364. doi: 10.1371/journal.pone.0017364. PLoS One. 2011. PMID: 21387004 Free PMC article.
-
Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy.J Immunol Res. 2018 Mar 18;2018:3982942. doi: 10.1155/2018/3982942. eCollection 2018. J Immunol Res. 2018. PMID: 29744371 Free PMC article.
-
Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.J Biol Chem. 2015 May 8;290(19):12394-402. doi: 10.1074/jbc.M114.628578. Epub 2015 Mar 26. J Biol Chem. 2015. PMID: 25814664 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
